Adjunctive D-cycloserine may enhance antidepressant effect of transcranial magnetic stimulation in MDD Dr. Shivi Kataria27 Oct 2022 8:00 PM ISTThe antidepressant effects of transcranial magnetic stimulation (TMS) protocols for major depressive disorder (MDD) are thought to depend on synaptic...
Treatment-resistant depression improves with ketamine infusion: JAMA Dr. Kamal Kant Kohli20 Oct 2022 9:45 AM ISTUSA: According to a report published in JAMA Psychiatry, when treatment-resistant depression patients were compared to healthy controls, belief...
Major Depressive Disorder Benefits from Adding D-cycloserine to Brain Stimulation: JAMA Dr. Kamal Kant Kohli19 Oct 2022 10:00 AM ISTCANADA: A randomized study published in JAMA Psychiatry demonstrated that D-cycloserine as an adjunctive may improve the outcomes of intermittent...
Frequent nightmares closely associated with suicide risk: Study Jacinthlyn Sylvia29 Sept 2022 9:30 AM ISTChina: Teenagers with major depressive disorder (MDD) had more frequent nightmares and were more distressed by their dreams, says an article published...
Omega-3 fatty acids reduce negative impact of major depressive disorder among obese Dr. Kamal Kant Kohli12 Sept 2022 8:00 PM ISTMassachusetts: Researchers at Emory University and Massachusetts General Hospital have found in a new study that Omega-3 fatty acids reduce negative...
Electroconvulsive treatment improves major depressive disorder when introduced earlier: Study Jacinthlyn Sylvia31 Aug 2022 8:00 PM ISTJapan: The prediction model created by Kazuki Nakajima and colleagues for electroconvulsive treatment (ECT) remission suggests that introducing ECT...
Escitalopram therapy effective against major depressive disorder: Study Jacinthlyn Sylvia30 Aug 2022 9:00 AM ISTUSA: A recent study published in the Journal of Affective Disorders explained intriguing biomarkers based on brain controllability to mechanistically...
Axsome Therapeutics gets USFDA nod for AUVELITY to treat Major Depressive Disorder in adults Ruchika Sharma20 Aug 2022 5:48 PM ISTNew York: Axsome Therapeutics, Inc., a biopharmaceutical company developing and delivering novel therapies for the management of central nervous...
Unichem Labs bags USFDA nod for Bipolar disorder drug Ruchika Sharma16 Aug 2022 5:00 PM ISTNew Delhi: Unichem Laboratories Limited today announced that the company has received Abbreviated New Drug Application (ANDA) approval for its...
Electroconvulsive therapy ineffective in reducing suicide risk among patients with depression Dr. Hiral patel22 July 2022 7:45 PM ISTUK: A course of electroconvulsive therapy (ECT) is not associated with a decreased risk of death by suicide in the patient suffering from depression...
Vortioxetine effective for treatment of major depressive disorders finds study Jacinthlyn Sylvia18 July 2022 11:00 AM ISTIn a new study published in Frontiers in Psychiatry, it was shown that vortioxetine is more effective in treating Major Depressive Disorder (MDD) in...
Dextromethorphan-bupropion safe and effective treatment for major depression: Study Dr. Hiral patel12 July 2022 2:15 AM ISTUSA: Dextromethorphan-bupropion (AXS-05) is efficient in improving depressive symptoms in patients with major depression compared to bupropion alone...
